Veterinary Infusion Pumps Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Veterinary Infusion Pumps Market is Segmented By Type (Large-Volume Infusion Pumps, Syringe Infusion Pumps), By Mobility (Stationary, Portable), By Channel Type (Single Channel, Multi-Channel), By Infusion Mode (Rate Mode, Time Mode, Dose Mode, Others), By End user (Veterinary Hospitals, Veterinary Clinics, Laboratories, Homecare, Others), and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Veterinary Infusion Pumps Market Overview

[200 Pages Report] Veterinary Infusion Pumps Market is estimated to reach at a high CAGR during the forecast period (2023-2030).

The veterinary infusion pump is a device used to deliver nutrient solutions to seriously ill pets over a lengthy period and is dosed fashioned. Veterinarian infusion pumps have been essential in monitoring and analyzing fluids for various clinical problems in animals. It administers a controlled supply of nutrition, drugs, and fluids to the patient's body in precise amounts at regular intervals. These pumps' bolus dosage, preprogramming, and standby mode capabilities can completely change how blood medicines are administered.

Veterinary Infusion Pumps Market - Strategic Insights

To Get a Free Sample Click here

Veterinary Infusion Pumps Market Dynamics

Innovations in Veterinary Infusion Pumps are expected to drive market growth.

Advancements in implanted drug delivery systems are necessary for novel pharmacological substances, such as particular biologics, gene therapy, and other tiny molecules that cannot be delivered orally, topically, or intravenously. This invasive dosing strategy aims to directly overcome physiological barriers posed by the animal body, release the appropriate medication dosage at the treatment site, and maintain the medication's bioavailability for the necessary period following delivery to ensure medication efficacy. Modern MEMS-enabled implanted medication infusion pumps with distinctive performance and feature sets have been made possible by microtechnological advancements. Acute fast radiolabeling, short-term administration of nanomedicine for cancer treatment, and chronic ocular medication dosage are a few examples of in vivo demonstration of micropumps for laboratory animal research and preclinical studies. Moreover, Next-generation implantable pumps with excellent performance in a small form factor for clinical applications may be made possible through research into MEMS actuators, valves, and other microstructures. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint

The high cost of veterinary infusion pumps, stringent regulations for the approvals of the devices, lack of awareness of animal health among the proprietors and errors of fluid infusion pumps using different administration sets are some of the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The veterinary infusion pumps market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. For therapeutic or diagnostic purposes, infusion pumps are machines that accurately provide liquids via intravenous (IV) or epidural methods. Compared to gravity administration sets, they offer higher pressures and greater accuracy. Infusion pumps provide a significant risk to pets, so extra caution should be used while administering IV solutions or medications. The patient may suffer harm if the infusion rate or volume are set incorrectly. Every infusion device should be utilized while the pets are being closely watched.

In contrast, an economic crisis will affect agriculture and veterinary services, and a greater emphasis on the public health effects of coronavirus infections in animals on farms and pets. Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Veterinary Infusion Pumps Market Segment Analysis

Large-Volume Infusion Pumps segment is expected to hold the largest market share in veterinary infusion pumps market

The large-volume infusion pumps segment is expected to dominate in 2021. The segment benefits as the infusion pumps can be manually or mechanically operated, offering great pain relief, fewer side effects than oral pharmaceutical treatment, and accessibility for daily tasks. Also, various infusion pumps are categorized into several categories based on their size, accuracy, technology, flow rate, battery life, and kind of infusions (continuous, intermittent). Therefore, it has led to the increased usage of large volume infusion pumps for administering parenteral nourishment, delivering fluid for blood transfusions, and in emergencies, with technological advancements in large volume infusion pumps. For instance, the IVVet Veterinary Infusion Pump from Eitan Medical combines the proprietary Flow Control Technology, state-of-the-art hardware design, user-friendly touch-screen, software-controlled pumping mechanism, and low total cost of ownership. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.     

Veterinary Infusion Pumps Market Geographical Share

North America region holds the largest market share in the global veterinary infusion pumps market

In 2021, North America accounted for the highest revenue share. The significant growth rate is owing to the increase in animal adaptation rates and healthcare expenditure coupled with rising animal diseases requiring surgeries. The huge number of veterinary practices and product launches by the market players are some factors the market is expected to boost in the forecast period. For instance, according to the American Society for the Prevention of Cruelty to Animals, every year, almost 4.1 million pets are adopted from animal shelters. On average, 2.1 million cats and 2 million dogs are adopted yearly. In contrast to dogs, which are more frequently bought from breeders than adopted, cats are adopted more frequently than they are bought from breeders. Moreover, according to the Veterinary Medical Association 2020, as of December 2020, there were around 75,349 veterinarian private offices in the United States.

Additionally, to establish a national sales presence in the veterinary healthcare equipment industry, DVMPro Inc., a top supplier of veterinary diagnostic equipment for veterinary health professionals, partnered with MTMC Animal Health. The relationship between MTMC and DVMPro will cover the entire product line, which comprises Veterinary Monitoring, Ventilators & Anesthesia, Ultrasound, ECG, Infusion Pumps, Pulse Oximetry, and Blood Analysis. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Veterinary Infusion Pumps Market Companies

Major key players in the veterinary infusion pumps market are B. Braun Melsungen AG, Burtons Medical Equipment Ltd, Digicare Biomedical Technology Inc., DRE Veterinary, Grady Medical System Inc., Heska Corporation, Jorgen Kruuse, Jorgensen Laboratories, Eitan Medical, iVet Medical.       

B. Braun Melsungen AG:

Overview:

B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, pain therapy products, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, ostomy, disinfection, and wound care products. The company operates its business through five divisions: hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM) and other sales. B. Braun has a presence in 64 countries and develops products in 18 therapy fields of the healthcare industry.

­Product Portfolio:

Infusomat Space pump: The Infusomat Space pump is a volumetric infusion pump configured as an individual pump, a small therapy unit, or an advanced infusion system. The pump's compact, lightweight, and user-friendly designs unify all clinical areas into a single system while offering a user-friendly solution to complex therapies.

The global veterinary infusion pumps market report would provide an access to an approx. 45+market data table, 40+figures and 200pages.